Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px
Organisation › Details

Ziylo Ltd.

Ziylo is a supramolecular chemistry company that has developed a third 'biomimetic' class of glucose binding molecules (GBMs). These molecules have potential to be a critical component in medical devices such as Continuous Glucose Monitors (CGM) and therapeutics such as Glucose Responsive Insulins (GRIs). The platform technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis' group at the University of Bristol and originally inspired by nature's carbohydrate-binding molecules (lectins). Ziylo was founded by (Director) Professor Anthony Davis, (CFO) Tom Smart and (CEO) Dr Harry Destecroix, who set up Ziylo while finishing his PhD in the Davis lab. Other directors of Ziylo include Keith MacDonald, an experienced chairman and the primary investor, and Dr Andrew Chapman (CSO) who has led the development of Ziylo's science. Colpman Consulting Ltd acted as lead business advisor in the sale process. The management team and board at Ziylo has founded a new company, Carbometrics, which has an exclusive license to develop applications in diagnostics and continuous glucose monitoring. Carbometrics will continue at Unit DX. *


Period Start 2014-05-14 established
  Predecessor University of Bristol
Products Industry analytical instrument
  Industry 2 chemistry (science)
Person Person Destecroix, Harry (Ziylo 201711 Managing Director + Unit DX 201711 Managing Director + Co-Founder)
Region Region Bristol
  Country United Kingdom (GB)
  Street Albert Road, St Philips Central
Unit DX
  City BS2 0XJ Bristol
    Address record changed: 2018-08-21
Basic data Employees A: 1 to 10 (2017-05-25)
    * Document for �About Section�: Novo Nordisk A/S. (8/17/18). "Press Release: Novo Nordisk Acquires Ziylo Ltd to Accelerate Its Development of Glucose Responsive Insulins". Bristol & Copenhagen.
Record changed: 2018-09-28


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Ziylo Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px

» top